bristol-myers squibb co
(BMY:New York Consolidated)
Beth C. Seidenberg M.D.
|Age||Total Calculated Compensation||This person is connected to 114 board members in 16 different organizations across 20 different industries.|
See Board Relationships
Dr. Beth C. Seidenberg, M.D., serves as a Partner, Managing Director, General Partner, and Investment Partner at Kleiner Perkins Caufield & Byers. Dr. Seidenberg is a part of the life sciences team investing in digital health and biotech. She works with entrepreneurs to develop companies with breakthrough technology to treat patients and improve health. She serves as Partner of Kleiner Perkins Caufield & Byers XVI, LLC and Kleiner Perkins Caufield & Byers XII, L.P. For ...
345 Park AvenuePhone: 212-546-4000
New York, New York 10154
Board Members Memberships*
Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director and Member of Audit Committee
Director and Chairman of Nominating & Corporate Governance Committee
University Of Miami School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Omar S. Ishrak||Chairman and Chief Executive Officer|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Lars Rebien Sørensen||Chief Executive Officer, President and Member of Executive Management|
Novo Nordisk A/S
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.6M||Compensation as of Fiscal Year 2015.|